Metraipolis › archive › dc_96030f82f135

Advancements in nanomedicine for the therapeutic regulation of efferocytosis: opportunities and challenges — Europe PMC PMID:41993634

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41993634
DOI
10.7150/thno.128155
License (as archived)
solo-consultazione
Archived
2026-11-03T23:04:24.394Z
SHA-256 of the archived text
6469ce96d8cf500a6cad704b79c7a609fb43a5a09980e6ef1f9cf751f2854a37
Stable URL of this page
https://metraipolis.com/documento/dc_96030f82f135

How to cite

Advancements in nanomedicine for the therapeutic regulation of efferocytosis: opportunities and challenges — Europe PMC PMID:41993634 — Europe PMC (en), https://europepmc.org/article/MED/41993634 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_96030f82f135 (Metraipolis archive dc_96030f82f135, sha256 6469ce96d8cf500a6cad704b79c7a609fb43a5a09980e6ef1f9cf751f2854a37)
BibTeX
@misc{dc96030f82f135,
  title = {Advancements in nanomedicine for the therapeutic regulation of efferocytosis: opportunities and challenges — Europe PMC PMID:41993634},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41993634},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_96030f82f135; sha256 6469ce96d8cf500a6cad704b79c7a609fb43a5a09980e6ef1f9cf751f2854a37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41993634. Agents can read the archived copy with the MCP tool read_document.